Surgeon Preference and Clinical Outcome of 3D Vision Compared to 2D Vision in Laparoscopic Surgery: Systematic Review and Meta-Analysis of Randomized Trials

R. Amiri, Maurice J. Zwart, Leia R. Jones, M. Abu Hilal, H. Beerlage, M. I. van Berge Henegouwen, W. Laméris, W. A. Bemelman, M. Besselink
{"title":"Surgeon Preference and Clinical Outcome of 3D Vision Compared to 2D Vision in Laparoscopic Surgery: Systematic Review and Meta-Analysis of Randomized Trials","authors":"R. Amiri, Maurice J. Zwart, Leia R. Jones, M. Abu Hilal, H. Beerlage, M. I. van Berge Henegouwen, W. Laméris, W. A. Bemelman, M. Besselink","doi":"10.1097/as9.0000000000000415","DOIUrl":null,"url":null,"abstract":"\n \n To assess the added value of 3-dimensional (3D) vision, including high definition (HD) technology, in laparoscopic surgery in terms of surgeon preference and clinical outcome.\n \n \n \n The use of 3D vision in laparoscopic surgery has been suggested to improve surgical performance. However, the added value of 3D vision remains unclear as a systematic review of randomized controlled trials (RCTs) comparing 3D vision including HD technology in laparoscopic surgery is currently lacking.\n \n \n \n A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines with a literature search up to May 2023 using PubMed and Embase (PROSPERO, CRD42021290426). We included RCTs comparing 3D versus 2-dimensional (2D) vision in laparoscopic surgery. The primary outcome was operative time. Meta-analyses were performed using the random effects model to estimate the pooled effect size expressed in standard mean difference (SMD) with corresponding 95% confidence intervals (CIs). The level of evidence and quality was assessed according to the Cochrane risk of bias tool.\n \n \n \n Overall, 25 RCTs with 3003 patients were included. Operative time was reduced by 3D vision (−8.0%; SMD, −0.22; 95% CI, −0.37 to −0.06; P = 0.007; n = 3003; 24 studies; I\n 2 = 75%) compared to 2D vision. This benefit was mostly seen in bariatric surgery (−16.3%; 95% CI, −1.28 to −0.21; P = 0.006; 2 studies; n = 58; I\n 2 = 0%) and general surgery (−6.7%; 95% CI, −0.34 to −0.01; P = 0.036; 9 studies; n = 1056; I\n 2 = 41%). Blood loss was nonsignificantly reduced by 3D vision (SMD, −0.33; 95% CI, −0.68 to 0.017; P = 0.060; n = 1830; I\n 2 = 92%). No differences in the rates of morbidity (14.9% vs 13.5%, P = 0.644), mortality (0% vs 0%), conversion (0.8% vs 0.9%, P = 0.898), and hospital stay (9.6 vs 10.5 days, P = 0.078) were found between 3D and 2D vision. In 15 RCTs that reported on surgeon preference, 13 (87%) reported that the majority of surgeons favored 3D vision.\n \n \n \n Across 25 RCTs, this systematic review and meta-analysis demonstrated shorter operative time with 3D vision in laparoscopic surgery, without differences in other outcomes. The majority of surgeons participating in the RCTs reported in favor of 3D vision.\n","PeriodicalId":503165,"journal":{"name":"Annals of Surgery Open","volume":"15 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgery Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/as9.0000000000000415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To assess the added value of 3-dimensional (3D) vision, including high definition (HD) technology, in laparoscopic surgery in terms of surgeon preference and clinical outcome. The use of 3D vision in laparoscopic surgery has been suggested to improve surgical performance. However, the added value of 3D vision remains unclear as a systematic review of randomized controlled trials (RCTs) comparing 3D vision including HD technology in laparoscopic surgery is currently lacking. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines with a literature search up to May 2023 using PubMed and Embase (PROSPERO, CRD42021290426). We included RCTs comparing 3D versus 2-dimensional (2D) vision in laparoscopic surgery. The primary outcome was operative time. Meta-analyses were performed using the random effects model to estimate the pooled effect size expressed in standard mean difference (SMD) with corresponding 95% confidence intervals (CIs). The level of evidence and quality was assessed according to the Cochrane risk of bias tool. Overall, 25 RCTs with 3003 patients were included. Operative time was reduced by 3D vision (−8.0%; SMD, −0.22; 95% CI, −0.37 to −0.06; P = 0.007; n = 3003; 24 studies; I 2 = 75%) compared to 2D vision. This benefit was mostly seen in bariatric surgery (−16.3%; 95% CI, −1.28 to −0.21; P = 0.006; 2 studies; n = 58; I 2 = 0%) and general surgery (−6.7%; 95% CI, −0.34 to −0.01; P = 0.036; 9 studies; n = 1056; I 2 = 41%). Blood loss was nonsignificantly reduced by 3D vision (SMD, −0.33; 95% CI, −0.68 to 0.017; P = 0.060; n = 1830; I 2 = 92%). No differences in the rates of morbidity (14.9% vs 13.5%, P = 0.644), mortality (0% vs 0%), conversion (0.8% vs 0.9%, P = 0.898), and hospital stay (9.6 vs 10.5 days, P = 0.078) were found between 3D and 2D vision. In 15 RCTs that reported on surgeon preference, 13 (87%) reported that the majority of surgeons favored 3D vision. Across 25 RCTs, this systematic review and meta-analysis demonstrated shorter operative time with 3D vision in laparoscopic surgery, without differences in other outcomes. The majority of surgeons participating in the RCTs reported in favor of 3D vision.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腹腔镜手术中 3D 视觉与 2D 视觉相比的外科医生偏好和临床结果:随机试验的系统回顾和元分析
从外科医生的偏好和临床效果的角度评估腹腔镜手术中三维(3D)视觉(包括高清(HD)技术)的附加值。 有人认为在腹腔镜手术中使用三维视觉可提高手术效果。然而,由于目前缺乏对腹腔镜手术中包括高清技术在内的三维视觉进行比较的随机对照试验(RCT)的系统回顾,因此三维视觉的附加值仍不明确。 根据系统综述和元分析首选报告项目(PRISMA)指南,我们利用 PubMed 和 Embase(PROSPERO,CRD42021290426)对截至 2023 年 5 月的文献进行了检索。我们纳入了比较腹腔镜手术中 3D 视觉与 2D 视觉的 RCT。主要结果是手术时间。我们使用随机效应模型进行了 Meta 分析,以标准均值差异 (SMD) 和相应的 95% 置信区间 (CI) 来估算汇总效应大小。证据水平和质量根据科克伦偏倚风险工具进行评估。 总共纳入了 25 项 RCT,共 3003 名患者。与二维视觉相比,三维视觉缩短了手术时间(-8.0%;SMD,-0.22;95% CI,-0.37 至 -0.06;P = 0.007;n = 3003;24 项研究;I 2 = 75%)。这种益处主要体现在减肥手术(-16.3%;95% CI,-1.28 到 -0.21;P = 0.006;2 项研究;n = 58;I 2 = 0%)和普通手术(-6.7%;95% CI,-0.34 到 -0.01;P = 0.036;9 项研究;n = 1056;I 2 = 41%)中。3D 视觉技术可显著减少失血量(SMD,-0.33;95% CI,-0.68 至 0.017;P = 0.060;n = 1830;I 2 = 92%)。在发病率(14.9% vs 13.5%,P = 0.644)、死亡率(0% vs 0%)、转院率(0.8% vs 0.9%,P = 0.898)和住院时间(9.6 vs 10.5 天,P = 0.078)方面,3D 和 2D 视觉没有发现差异。在 15 项报告了外科医生偏好的研究中,有 13 项(87%)报告称大多数外科医生偏好 3D 视觉。 这项系统性回顾和荟萃分析显示,在 25 项研究中,腹腔镜手术中使用 3D 视觉的手术时间更短,但其他结果没有差异。大多数参与研究实验的外科医生都表示支持 3D 视觉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Within-hospital Temporal Clustering of Postoperative Complications and Implications for Safety Monitoring and Benchmarking Using ACS-NSQIP Data Association Between Surgeon Sex and Days Alive at Home Following Surgery: A Population-Based Cohort Study Response to Comment by Dr. Kuang on Our Manuscript “Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial)” Visual Mapping of Operating Theater Team Dynamics and Communication for Reflexive Feedback and Surgical Practice Optimization Surgical Outcomes and Sociodemographic Disparities Across All Races: An ACS-NSQIP and NHIS Multi-Institutional Analysis of Over 7.5 Million Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1